Professor and Georgia Tech Ocean Science and Engineering Co-Director Annalisa Bracco serves as the scientific advisor for Around the Blue, a new docufilm on ocean sustainability that follows ocean navigator Giovanni Soldini as he sails around the world, interviewing scientists working towards solutions for our oceans at each stop.

Presented at the Venice Film Festival on September 7 and endorsed by the UN Ocean Decade, the film will be released on Amazon towards the end of this year. Stay tuned at AroundtheBlue.org for the film’s public release in November, with English subtitles.

Related coverage: Giornale della Vela, Corriere della Sera, CNR, Style Magazine, Ciak Magazine, Press Mare, Seven Press, Il Messaggero, Daily Media/ecostampa.it, PUBBLICOMNOW, Touchpoint Today, SKYTG24, Rai Radio1, fattitaliani.it, spettacolomusicasport.com, orgoglionerd.it, and more.

A study on the magnitude M 7.6 earthquake Noto Hanto, which struck Japan's Noto Peninsula on January 1st, 2024, shows it was preceded by a series of foreshocks including three significant events (M 5.5, M 4.6, and M 5.9). These foreshocks occurred just seconds to minutes before the main shock and underscores a complex behavior change from the long-term swarm-like activities to the burst-like foreshock activities. School of Earth and Atmospheric Sciences Professor Zhigang Peng talks about the importance of this study. 

"While other recently published studies focused on one aspect of the Noto sequence, such as the mainshock rupture or relocation of small earthquakes, this study combines results from many different angles, including relocations of all seismic events since 2018," says Peng. "Hence, it is likely one of the most complete analyses so far for this sequence."

Researchers at Georgia Tech, led by School of Chemistry and Biochemistry Professor M.G. Finn , along with researchers from MIT, revealed a new strategy for enabling immune system mobilization against cancer cells. The work, which appears in ACS Nano, produces exactly the type of anti-tumor immunity needed to function as a tumor vaccine - both prophylactically and therapeutically. Finn's research, along with two other groups, had previously identified a synthetic DC-SIGN binding group that directed cellular immune responses when used to decorate virus-like particles. But it was unclear whether this method could be utilized as an anticancer vaccine. Collaboration between researchers in the labs at MIT and Georgia Tech demonstrated that in fact, it could.